SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shuangling Zhong, Chenggang Sun, Sen Dou, Wencong Liu, Pd-catalyzed desulfitative and denitrogenative Suzuki-type reaction of arylsulfonyl hydrazides, RSC Adv., 2015, 5, 34, 27029

    CrossRef

  2. 2
    S. S. Sheen, R. W. Park, D. Yoon, G.-T. Shin, H. Kim, I.-W. Park, The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users, Journal of Clinical Pharmacy and Therapeutics, 2015, 40, 1
  3. 3
    William J. Elliott, Treatment, Journal of the American Society of Hypertension, 2015, 9, 3, 239

    CrossRef

  4. 4
    Ulrich Strassen, Murat Bas, Thomas K. Hoffmann, Andreas Knopf, Jens Greve, Treatment of angiotensin receptor blocker-induced Angioedema: A case series, The Laryngoscope, 2015, 125, 5
  5. 5
    Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger S. Blumenthal, Christopher P. Cannon, James A. de Lemos, William J. Elliott, Laura Findeiss, Bernard J. Gersh, Joel M. Gore, Daniel Levy, Janet B. Long, Christopher M. O'Connor, Patrick T. O'Gara, Olugbenga Ogedegbe, Suzanne Oparil, William B. White, Treatment of hypertension in patients with coronary artery disease, Journal of the American Society of Hypertension, 2015,

    CrossRef

  6. 6
    Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger S. Blumenthal, Christopher P. Cannon, James A. de Lemos, William J. Elliott, Laura Findeiss, Bernard J. Gersh, Joel M. Gore, Daniel Levy, Janet B. Long, Christopher M. O’Connor, Patrick T. O’Gara, Olugbenga Ogedegbe, Suzanne Oparil, William B. White, Treatment of Hypertension in Patients With Coronary Artery Disease, Journal of the American College of Cardiology, 2015, 65, 18, 1998

    CrossRef

  7. 7
    Csaba András Dézsi, A review of clinical studies on angiotensin II receptor blockers and risk of cancer, International Journal of Cardiology, 2014, 177, 3, 748

    CrossRef

  8. 8
    Ricardo Fernández-Musoles, María Castelló-Ruiz, Cristina Arce, Paloma Manzanares, M. Dolores Ivorra, Juan B. Salom, Antihypertensive Mechanism of Lactoferrin-Derived Peptides: Angiotensin Receptor Blocking Effect, Journal of Agricultural and Food Chemistry, 2014, 62, 1, 173

    CrossRef

  9. 9
    Ryuichi Ogawa, Joan M. Stachnik, Hirotoshi Echizen, Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally), Clinical Pharmacokinetics, 2014, 53, 12, 1083

    CrossRef

  10. 10
    Atsushi Sakima, Toshihiro Kita, Seigo Nakada, Naoto Yokota, Noboru Tamaki, Takuma Etoh, Toru Shimokubo, Kazuo Kitamura, Shuichi Takishita, Yusuke Ohya, Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers, Clinical and Experimental Hypertension, 2014, 36, 1, 40

    CrossRef

  11. 11
    Iratxe Huerta, Maitane Barasoain, Mercedes Télez, Mikel Longa, Javier Muga, Gorka Barrenetxea, Eduardo Ortiz-Lastra, Javier González, Begoña Criado, Isabel Arrieta, Genotoxic evaluation of five Angiotesin II receptor blockers: In vivo and in vitro micronucleus assay, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2014, 767, 1

    CrossRef

  12. 12
    I.-W. Park, S. S. Sheen, D. Yoon, S.-H. Lee, G.-T. Shin, H. Kim, R. W. Park, Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?, Journal of Clinical Pharmacy and Therapeutics, 2014, 39, 1
  13. 13
    Cheng Gong, Junfeng Wang, Yinghua Sun, Dawei Ding, Lu Zhong, Meng Zhu, Jin Sun, Xiangrong Zhang, UPLC–MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study, Asian Journal of Pharmaceutical Sciences, 2014,

    CrossRef

  14. 14
    Howard Lee, Kee Sik Kim, Shung Chull Chae, Myung Ho Jeong, Dong-Soo Kim, Byung-Hee Oh, Ambulatory Blood Pressure Response to Once-Daily Fimasartan: An 8-Week, Multicenter, Randomized, Double-Blind, Active-Comparator, Parallel-Group Study in Korean Patients With Mild To Moderate Essential Hypertension, Clinical Therapeutics, 2013, 35, 9, 1337

    CrossRef

  15. 15
    Sverre Kjeldsen, Giuseppe Mancia, Roland Schmieder, Michaela Mattheus, Thomas Unger, An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors, Expert Review of Cardiovascular Therapy, 2013, 11, 6, 673

    CrossRef

  16. 16
    Romina Hernández-Salinas, Alejandra Z. Vielma, Marlene N. Arismendi, Mauricio P. Boric, Juan C. Sáez, Victoria Velarde, Boldine Prevents Renal Alterations in Diabetic Rats, Journal of Diabetes Research, 2013, 2013, 1

    CrossRef

  17. 17
    Periyathambi Kalaivani, Ramesh Babu Saranya, Ganapathy Ramakrishnan, Vijayan Ranju, Sekar Sathiya, Veeraraghavan Gayathri, Lakshmi Kantham Thiyagarajan, Jayakothanda Ramaswamy Venkhatesh, Chidambaram Saravana Babu, Sadagopan Thanikachalam, Cuminum cyminum, a Dietary Spice, Attenuates Hypertension via Endothelial Nitric Oxide Synthase and NO Pathway in Renovascular Hypertensive Rats, Clinical and Experimental Hypertension, 2013, 35, 7, 534

    CrossRef

  18. You have free access to this content18
    Joseph J. Saseen, Vahram Ghushchyan, Shuchita Kaila, Richard R. Allen, Kavita V. Nair, Maintaining Goal Blood Pressures After Switching From Olmesartan to Other Angiotensin Receptor Blockers, The Journal of Clinical Hypertension, 2013, 15, 12
  19. 19
    Gerhard Burckhardt, Drug transport by Organic Anion Transporters (OATs), Pharmacology & Therapeutics, 2012, 136, 1, 106

    CrossRef

  20. 20
    Howard Lee, Han-Mo Yang, Hae-Young Lee, Jae-Joong Kim, Dong-Ju Choi, Ki-Bae Seung, Eun-Seok Jeon, Jong-Won Ha, Se-Joong Rim, Jeong Bae Park, Joon-Han Shin, Byung-Hee Oh, Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies, Clinical Therapeutics, 2012, 34, 6, 1273

    CrossRef

  21. 21
    LM Ruilope, Helmut Schumacher, Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension, Expert Opinion on Pharmacotherapy, 2012, 13, 16, 2417

    CrossRef

  22. 22
    Jennifer L. Wilkinson-Berka, Alex Agrotis, Devy Deliyanti, The retinal renin–angiotensin system: Roles of angiotensin II and aldosterone, Peptides, 2012, 36, 1, 142

    CrossRef

  23. You have free access to this content23
    Keith C. Ferdinand, A Compendium of Antihypertensive Therapy, The Journal of Clinical Hypertension, 2011, 13, 9